Activity Cliff Prediction: Dataset and Benchmark
Not on the map. Why?
Abstract (arXiv)
Activity cliffs (ACs), which are generally defined as pairs of structurally similar molecules that are active against the same bio-target but significantly different in the binding potency, are of great importance to drug discovery. Up to date, the AC prediction problem, i.e., to predict whether a pair of molecules exhibit the AC relationship, has not yet been fully explored. In this paper, we first introduce ACNet, a large-scale dataset for AC prediction. ACNet curates over 400K Matched Molecular Pairs (MMPs) against 190 targets, including over 20K MMP-cliffs and 380K non-AC MMPs, and provides five subsets for model development and evaluation. Then, we propose a baseline framework to benchmark the predictive performance of molecular representations encoded by deep neural networks for AC prediction, and 16 models are evaluated in experiments. Our experimental results show that deep learning models can achieve good performance when the models are trained on tasks with adequate amount of data, while the imbalanced, low-data and out-of-distribution features of the ACNet dataset still make it challenging for deep neural networks to cope with. In addition, the traditional ECFP method shows a natural advantage on MMP-cliff prediction, and outperforms other deep learning models on most of the data subsets. To the best of our knowledge, our work constructs the first large-scale dataset for AC prediction, which may stimulate the study of AC prediction models and prompt further breakthroughs in AI-aided drug discovery. The codes and dataset can be accessed by https://drugai.github.io/ACNet/.
Key facts. Cited by 11 papers in the map (data through 7 Oct 2026). Builds on 15 of its 56 references that are in the map. First posted on arXiv 15 Feb 2023.
Builds on
15 of 56 references.
References · 15
- 2016Semi-Supervised Classification with Graph Convolutional Networkscited by 11,282
- 2018How Powerful are Graph Neural Networks?cited by 4,355
- 2019Simplifying Graph Convolutional Networkscited by 1,470
- 2014On the Properties of Neural Machine Translation: Encoder-Decoder Approachescited by 1,303
- 2017MoleculeNet: A Benchmark for Molecular Machine Learningcited by 1,037
- 2019Strategies for Pre-training Graph Neural Networkscited by 964
- 2021Generalizing to Unseen Domains: A Survey on Domain Generalizationcited by 762
- 2021OGB-LSC: A Large-Scale Challenge for Machine Learning on Graphscited by 328
- 2021Do Transformers Really Perform Bad for Graph Representation?cited by 318
- 2021Pre-training Molecular Graph Representation with 3D Geometrycited by 248
- 2021Deep Stable Learning for Out-Of-Distribution Generalizationcited by 153
- 2021Self-supervised Graph-level Representation Learning with Local and Global Structurecited by 125
Built on by
Citing papers per year: 2023: 2; 2024: 4; 2025: 3; 2026: 2.
11 papers.
- 2023Lo-Hi: Practical ML Drug Discovery Benchmarkcited by 10
- 2025mCLM: A Modular Chemical Language Model that Generates Functional and Makeable Moleculescited by 8
- 2026MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimizationcited by 6
- 2023GeSS: Benchmarking Geometric Deep Learning under Scientific Applications with Distribution Shiftscited by 4
- 2024AMPCliff: quantitative definition and benchmarking of activity cliffs in antimicrobial peptidescited by 3
- 2024SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Designcited by 2
- 2024Contextual Molecule Representation Learning from Chemical Reaction Knowledgecited by 1
- 2025Conditional Chemical Language Models are Versatile Tools in Drug Discoverycited by 1
- 2025ATOM: A Pretrained Neural Operator for Multitask Molecular Dynamicscited by 1
- 2024MoleculeCLA: Rethinking Molecular Benchmark via Computational Ligand-Target Binding Analysiscited by 0
- 2026JEDEL: Zero-Shot DNA-Encoded Library Design for Early-Stage Drug Discoverycited by 0
- 2026JEDEL: Zero-Shot DNA-Encoded Library Design for Early-Stage Drug Discovery21 Jun 2026
- 2026MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization2 Apr 2026
- 2025ATOM: A Pretrained Neural Operator for Multitask Molecular Dynamics7 Oct 2025
- 2025Conditional Chemical Language Models are Versatile Tools in Drug Discovery14 Jul 2025
- 2025mCLM: A Modular Chemical Language Model that Generates Functional and Makeable Molecules18 May 2025
- 2024SynthFormer: Equivariant Pharmacophore-based Generation of Synthesizable Molecules for Ligand-Based Drug Design3 Oct 2024
- 2024MoleculeCLA: Rethinking Molecular Benchmark via Computational Ligand-Target Binding Analysis13 Jun 2024
- 2024AMPCliff: quantitative definition and benchmarking of activity cliffs in antimicrobial peptides15 Apr 2024
- 2024Contextual Molecule Representation Learning from Chemical Reaction Knowledge21 Feb 2024
- 2023GeSS: Benchmarking Geometric Deep Learning under Scientific Applications with Distribution Shifts12 Oct 2023
- 2023Lo-Hi: Practical ML Drug Discovery Benchmark10 Oct 2023